Cargando…
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
Endometrial cancer (EC) is the most common gynecologic malignancy and still remains clinically challenging. We aimed to explore the potential biomarkers of EC and provide a theoretical basis for early screening and targeted therapy. The available transcriptome data from The Cancer Genome Atlas (TCGA...
Autores principales: | Le, Lulu, Luo, Ji, Wu, Haifang, Chen, Ling, Tang, Xiaoli, Fu, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054569/ https://www.ncbi.nlm.nih.gov/pubmed/33782625 http://dx.doi.org/10.4081/ejh.2021.3226 |
Ejemplares similares
-
TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma
por: Shi, Ke, et al.
Publicado: (2023) -
Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018) -
Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma
por: Sun, Shan-Shan, et al.
Publicado: (2020) -
Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2
por: Fu, Junqi, et al.
Publicado: (2022) -
Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
por: Chen, Yu-Ling, et al.
Publicado: (2013)